Clinical Trial Update: Guadecitabine With or Without Idarubicin or Cladribine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating guadecitabine alone or in combination with idarubicin or cladribine in older adults with previously untreated acute myeloid leukemia;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Cladribine (cladribine)
• Idarubicin (idarubicin)
• SGI-110 (guadecitabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Untreated Adult Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2022-05-24